PRME
Prime Medicine, Inc.
3.10$
+4.7%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | -100.0% | – | +55.3% | |
| – | +8.0% | +63.1% | +147.2% | -61.3% | +31.7% | +19.5% | |
| – | – | -318.0% | – | – | – | -190.1% | |
| – | +223.9% | +2,267.4% | +22.9% | +70.5% | +5.0% | +3.4% | |
| – | -15.8% | +340.4% | +114.2% | +45.5% | +15.6% | +4.4% | |
| – | +45.6% | +2,571.5% | +38.0% | +75.7% | +0.3% | +0.1% | |
| – | – | – | – | – | – | – | |
| – | – | +697.3% | -85.2% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | +46,575.0% | -126.0% | – | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.